{"nctId":"NCT01565382","briefTitle":"Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)","startDateStruct":{"date":"2011-02"},"conditions":["Alzheimer's Disease"],"count":40,"armGroups":[{"label":"Independent, blinded reader trainees","type":"EXPERIMENTAL","interventionNames":["Drug: florbetapir F 18"]}],"interventions":[{"name":"florbetapir F 18","otherNames":["18F-AV-45","Amyvid","florbetapir"]}],"eligibilityModule":{"eligibilityCriteria":"Participants:\n\n* Inclusion Criteria AD:\n\n  * Male or female \\>=50 years of age\n  * Meet National Institute of Neurological and Communicative Disorders and Stroke (NINCDS) criteria for probable AD with Mini-Mental State Examination (MMSE) score of 10-24\n* Inclusion Criteria MCI:\n\n  * Male or female \\>=50 years of age\n  * Have a Clinical Dementia Rating (CDR) of 0.5\n  * MMSE \\>24\n* Exclusion Criteria:\n\n  * Have a history or current diagnosis of other neurologic disease\n  * Have had or currently have a diagnosis of other neurodegenerative disease\n  * Have participated in experimental therapy targeted to amyloid plaque\n\nReaders:\n\nâ€¢Private nuclear medicine physicians with no prior training in reading florbetapir-PET scans","healthyVolunteers":false,"sex":"ALL","minimumAge":"50 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Inter-reader Agreement - Median Kappa Statistic","description":"Seven readers blinded to all clinical information using the binary read methodology (amyloid positive/negative). Simple kappa statistics were calculated for each reader versus the other 6 readers. Primary outcome measure was the median kappa of each reader versus the other 6 readers.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.72","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.70","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.25","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.75","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.68","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.83","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.68","spread":null}]}]}]},{"type":"SECONDARY","title":"Overall Inter-reader Agreement - Fleiss' Kappa","description":"Seven readers blinded to all clinical information using the binary read methodology (amyloid positive/negative). Fleiss' kappa was calculated across all inter-reader comparisons.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.61","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}}